Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Weighted Avg Shares history
Shares · from the income statement
No Weighted Avg Shares data reported for this period type.
Weighted Avg Shares vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | 146.1M | +155.9% | +166.8% | |
| LTM Mar 2026 | 124.17M | +37.8% | +23.4% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | 115.39M | +93.7% | +384.0% |
| LTM Jun 2026 | 64.59M | +3.1% | +9.0% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | 61.01M | +68.6% | +46.8% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | 36.24M | +0.0% | — |
| LTM Mar 2026 | 28.59M | -2.5% | -0.4% | |
| LTM Mar 2026 | 19.58M | +98.7% | +69.8% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
| Peer median (excluding ODTX) | 62.8M | +53.2% | +46.8% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.